Raman Against Respiratory Infection

by Natasha Nater | Nov 17, 2023 | Case Studies

Raman Against Respiratory Infection Diagnosing a bacterial infection and determining the best treatment for it is typically a slow process, taking days, while successful clinical outcomes often depend on rapid prescription with effective antibiotics. This promotes the...

Using Synthetic Materials to Model Marine Biofilms

by Natasha Nater | Nov 17, 2023 | Case Studies

Using Synthetic Materials to Model Marine Biofilms Marine biofilms can cause up to an 11% increase in ship shaft power which has environmental and economic consequences. As biofilms are heterogeneous and adaptable, rigid models are often used as a benchmark for...

Rapid Sustainable Diagnostics

by Natasha Nater | Nov 17, 2023 | Case Studies

Rapid Sustainable Diagnostics Loughborough University based biotechnology startup, Cromerix, is working to tackle the growing global issues in healthcare, industry and home, due to microbial infections and contaminations, which have an economic impact of $5 trillion...

Improving Patients’ Quality of Life

by Natasha Nater | Nov 17, 2023 | Case Studies

Improving Patients’ Quality of Life According to the World Health Organization, each year, an estimated 4% of people with long-term urinary catheters will develop a CAUTI or blockage. Bacteria can enter the bladder during catheter insertion, through the catheter lumen...

Innovations in Wastewater Treatment

by Natasha Nater | Nov 17, 2023 | Case Studies

Innovations in Wastewater Treatment The Wastewater treatment (WWT) market is estimated to be worth over $300bn worldwide, yet globally 44% of municipal wastewater is not treated safely, with up to 2.3bn people not having access to basic sanitation. Recent news reports...

Nature Vs AMR

by Natasha Nater | Nov 17, 2023 | Case Studies

Nature Vs AMR Multi-Drug-Resistance bacterial infections pose a serious threat to global health due to increasing bacterial resistance against currently used antibiotics and the lack of new classes of antibiotics to combat resistant bacterial pathogens. In 2019,...